Post Hoc Subgroup Analysis of Clinical Outcomes in Patients With High-Risk Metastatic Hormone-Naïve Prostate Cancer: Results From a 3-Year Interim Analysis of the J-ROCK Study.

Prostate · 2026 · PMC12935391 · PMID 41524484

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Patients in cohort 1 with poor prognostic factors (older age, high GGG, low Hb, and elevated LDH) showed a trend towards earlier decline in OS than those in cohort 2B, which may indicate that caution is required when cohort 1 treatment is selected for patients with poor prognostic factors.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.